MBX 1416 is an investigational long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist in development as a potential ...

I enjoyed “Turning Down the Food Noise” [The New Science of Diet, Health and Appetite], Lauren J ... Several studies show ...

MORE: Weight loss plans are less effective for many Black women − because existing ones often don't meet their unique needs ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

Scurvy is a disease caused by a serious vitamin C deficiency and scientists claim it could be linked to medicines for ...

Sheila Hogan was a size 22 and a yo-yo dieter, but she now managed to lose 5st after she could barely climb the stairs and ...

Doctors told Sheila Hogan she was pre-diabetic and in that moments, she knew she couldn't rely on yo-yo dieting any longer ...

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Sheila Hogan, 60, from Edinburgh, was a size 22 and a yo-yo dieter - but she's now managed to lose five stone after she could barely climb the stairs and had digestive problems ...

It's hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that imitate the role of a hormone, GLP-1, that works to balance blood sugar and ...

Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...

Ozempic, a weight loss drug that has exploded in use across America, has joined a list of treatments that started with benign intentions and evolved into a reflection of the modern weight loss and ...